Brent Vernon

Dr. Brent Vernon

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Composites Part B: Engineering
Verified
Journal Article
Closed access
WXWeiheng Xu
Weiheng Xu
SJSayli Jambhulkar
Sayli Jambhulkar
YZYuxiang Zhu
Yuxiang Zhu
DRDharneedar Ravichandran
Dharneedar Ravichandran
MKMounika Kakarla
Mounika Kakarla
KENAN SONGKENAN SONG
KENAN SONG

20 April 2012 in Journal of Polymer Science Part B: Polymer Physics
Verified
Journal Article
Open access
PDF file
DODerek Overstreet
Derek Overstreet
DDDipankar Dutta
Dipankar Dutta
SSSarah E. Stabenfeldt
Sarah E. Stabenfeldt
BVBrent Vernon
Brent Vernon
Hydrogels are promising for a variety of medical applications due to their high water content and mechanical similarity to natural tissues. When made injectable, hydrogels can reduce the invasiveness of application, which in turn reduces surgical and recovery costs. Key schemes used to make hydrogels injectable include in situ formation due to physical and/or chemical cross‐linking. Advances in polymer science have provided new injectable hydrogels for applications in drug delivery and tissue engineering. A number of these injectable hydrogel systems have reached the clinic and impact the health care of many patients. However, a significant remaining challenge is translating the ever‐growing family of injectable hydrogels developed in laboratories around the world to the clinic. © 2012 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys, 2012

1 March 2007 in Tissue Engineering
Verified
Journal Article
Closed access
JBJonathan Beck
Jonathan Beck
RARyan Angus
Ryan Angus
BMBen Madsen
Ben Madsen
David BrittDavid Britt
David Britt
BVBrent Vernon
Brent Vernon
KNKytai T. Nguyen
Kytai T. Nguyen
Diabetes is one of the most prevalent, costly, and debilitating diseases in the world. Although traditional insulin therapy has alleviated the short-term effects, long-term complications are ubiquitous and harmful. For these reasons, alternative treatment options are being developed. This review investigates one appealing area: cell replacement using encapsulated islets. Encapsulation materials, encapsulation methods, and cell sources are presented and discussed. In addition, the major factors that currently limit cell viability and functionality are reviewed, and strategies to overcome these limitations are examined. This review is designed to introduce the reader to cell replacement therapy and cell and tissue encapsulation, especially as it applies to diabetes.

1 March 2016 in Acta Biomaterialia
Verified
Journal Article
Closed access
ANAli Navaei
Ali Navaei
DTDanh Truong
Danh Truong
JHJohn Heffernan
John Heffernan
JCJosh Cutts
Josh Cutts
DBDavid Brafman
David Brafman
MNMehdi Nikkhah
Mehdi Nikkhah

10 May 2006 in Biomacromolecules
Verified
Journal Article
Closed access
BLBae Hoon Lee
Bae Hoon Lee
BWBianca West
Bianca West
RMRyan McLemore
Ryan McLemore
CPChristine Pauken
Christine Pauken
BVBrent Vernon
Brent Vernon

4 May 2011 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
ZCZhanwu Cui
Zhanwu Cui
BLBae Hoon Lee
Bae Hoon Lee
CPChristine Pauken
Christine Pauken
BVBrent Vernon
Brent Vernon